PPARA and Alzheimer disease: The study by Chandra and Pahan [125] showed that gemfibrozil (an FDA-approved drug for hyperlipidemia) through PPAR-α decreased amyloid plaque and improved memory in a mouse model of AD (in 5xFAD).